KAPA

Kairos Pharma, Ltd.

9 hedge funds and large institutions have $123K invested in Kairos Pharma, Ltd. in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.

Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
3
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
XT
1
XTX Topco
Cayman Islands
$44.5K 62,746 +62,746 New
ACA
2
Aptus Capital Advisors
Alabama
$31.4K 44,286
Geode Capital Management
3
Geode Capital Management
Massachusetts
$15.5K 21,804 +1,371 +7%
TSS
4
Two Sigma Securities
New York
$9.61K 13,555 +13,555 New
HF
5
HRT Financial
New York
$9K 13,239 +13,239 New
UBS Group
6
UBS Group
Switzerland
$6.71K 9,458 +6,666 +239%
Citigroup
7
Citigroup
New York
$3.9K 5,499 +5,499 New
TRCT
8
Tower Research Capital (TRC)
New York
$2.69K 3,797 +3,797 New
Bank of America
9
Bank of America
North Carolina
$36 51 +30 +143%
AC
10
Armistice Capital
New York
-1,404,000 Closed
SRL
11
Scientech Research LLC
New Jersey
-48,198 Closed
Citadel Advisors
12
Citadel Advisors
Florida
-13,230 Closed